In tumor cells bearing IDH mutations, 2-HG can be accumulated at concentrations of millimolar level20, at which it competitively inhibits multiple α-KG/Fe(II)-dependent dioxygenases21,22, consequently interfering many relevant processes as epigenetic regulation, genetic instability, T cell differentiation and tumor immunity [reviewed in ref. 19]. Here, IDH2 is linked to neoplasm.